Canada's EcoSynthetix Q3 sales fall 38% on lower volumes, macroeconomic conditions

By Reuters News


Overview

  • Canada renewable chemicals firm's Q3 sales fell 38% yr/yr on lower volumes

  • Q3 adjusted EBITDA was nearly flat as lower gross profit offset by reduced operating costs

  • Company repurchased and cancelled 23,000 shares in Q3 under normal course issuer bid


Outlook

  • EcoSynthetix says macro dynamics in key end markets continue to weigh on sales volumes

  • Company prioritizes driving adoption within existing and new customers to return to growth

  • EcoSynthetix continues to work with key accounts to support higher usage of its biopolymers


Result Drivers

  • LOWER SALES VOLUMES - Co said Q3 sales fell due to reduced volumes in key end markets and challenging macroeconomic conditions

  • SLOWER CUSTOMER ADOPTION - Co said rate of adoption of its biopolymers was slower than anticipated, with strategic accounts using products at reduced levels

  • HIGHER AVERAGE SELLING PRICE - Co said higher average selling price, driven by product mix and FX, partially offset volume declines


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

$3.60 mln

Q3 Adjusted EBITDA

$39,437


Reuters Recommended Reads

  • Nov 2 - Canada's proposed new biofuels rules only a first step, industry says

  • Nov 3 - Rayonier Advanced Materials Q3 sales and EBITDA miss estimates on tariffs, impairments

  • Nov 2 - Chemours Q3 adjusted profit misses estimates despite titanium pricing gains


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.